Saket has over eight years of research and investment experience and holds a Ph.D. in Immunology & Microbiology. He has worked on projects related to infectious diseases, cancer, ophthalmology, and autoimmune diseases. He also holds a patent for a Hepatitis B antibody drug. Along with his early curiosity in investing in public markets and writing for The Motley Fool, Saket was part of a venture capital team at a family office for the past two years, where he invested in the life science vertical
Access investment thesis, focus areas, bio, and contact details for Saket Jhajharia and 22,000+ other VC professionals.
Singapore, SG